Nirianne Q. Palacpac
Suita, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Editorial: Dissecting malaria protective immunity: acquired by natural infection and/or vaccination.
Editorial: Dissecting malaria protective immunity: acquired by natural infection and/or vaccination.
Journal: Frontiers in immunology
Published: March 14, 2026
RH5.1/Matrix-M: highlighting blood-stage malaria vaccines.
Journal: The Lancet. Infectious diseases
Published: November 21, 2024
Understanding the immunogenicity of RTS,S in infants.
Journal: The Lancet. Infectious diseases
Published: September 02, 2024
Asymptomatic parasitemia and RTS,S vaccine efficacy.
Journal: The Lancet. Infectious diseases
Published: March 18, 2024
Persistence of Anti-SE36 Antibodies Induced by the Malaria Vaccine Candidate BK-SE36/CpG in 5-10-Year-Old Burkinabe Children Naturally Exposed to Malaria.
Journal: Vaccines
Published: December 15, 2023
Immune tolerance caused by repeated P. falciparum infection against SE36 malaria vaccine candidate antigen and the resulting limited polymorphism.
Journal: Parasitology international
Published: September 04, 2023
Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial.
Journal: Frontiers in immunology
Published: July 26, 2023
Editorial: Puzzle pieces from malaria vaccine clinical trials.
Journal: Frontiers in immunology
Published: January 06, 2023
Plasmodium falciparum infection coinciding with the malaria vaccine candidate BK-SE36 administration interferes with the immune responses in Burkinabe children.
Journal: Frontiers in immunology
Published: December 09, 2022
African-specific polymorphisms in Plasmodium falciparum serine repeat antigen 5 in Uganda and Burkina Faso clinical samples do not interfere with antibody response to BK-SE36 vaccination.
Journal: Frontiers in cellular and infection microbiology
Published: September 30, 2022
Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children.
Journal: Frontiers in immunology
Published: June 26, 2022
The Impact of Sequestration on Artemisinin-Induced Parasite Clearance in Plasmodium falciparum Malaria in Africa.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 17, 2022
Last Updated: 09/26/2026